Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Access of Pemigatinib to Treat a Single Patient With Metastatic Pancreatic Cancer

NCT03906357 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT03906357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03906357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Access of Pemigatinib to Treat a Single Patient With Metastatic Pancreatic Cancer
Lead sponsor
Incyte Corporation
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported